Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | 2-Chloroquinoline | HCID 11928 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Quipazine | HCID 5011 | 92% |
Reaction Steps
A mixture of 2-chloroquinoline (10.0 g, 60.5 mmol), piperazine (26.1 g, 303 mmol) and pyridine (15 ml) was heated reflux temperature for 4 h. The hot reaction mixture was poured into a conical flask and diluted with tetrahydrofuran (150 ml). The precipitated solid was filtered off and washed with diethyl ether (3×50 ml) and the combined organic phases were evaporated in vacuo. The residue was suspended in a mixture of diethyl ether (200 ml) and 96% ethanol (80 ml) and undissolved solid was filtered off and washed with diethyl ether. The organic phase was evaporated in vacuo affording a solid which was crushed under water (200 ml) filtered off and washed with water (3×50 ml), diethyl ether (3×40 ml), dried in vacuo at 50° C. affording 11.8 g (92%) of 2-(1-piperazinyl)quinoline as a solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06043247 |
|---|
| Source dataset | uspto-grants-2000_03 |
|---|
| ORD ID | ord-5d84abdf0a9946c7bd38c9223d049150 |
|---|
| Source note | uspto-grants-2000_03 |
|---|